Enzymeblocking Therapy for Cancer

Hormone-c/epenc/enf forms of cancer

H o r m o rie-independent forms of cancer

Stomach cancer

Breast cancer (Mammary Carcinoma)

Breast cancer (Mammary Carcinoma)

Colon cancer

Cancer of the womb (Uterine Carcinoma)

Cancer of the ovary (Ovarian Carcinoma)

Cancer of the womb (Uterine Carcinoma)

Skin cancer

This patient was treated with tranexamic acid, a synthetic derivative of the natural amino acid lysine. This chemically modified form of lysine is many times stronger than the natural substance; it is artificial and can be used by prescription only. High dosages of lysine will have a similar result but without the side effects associated with the use of tranexamic acid.

In the Journal of the American Medical Association (JAMA), July 11, 1977, the same research group presented spectacular successes in the treatment of ovarian tumors. Even in very advanced cases—with secondary tumors in other organs—the enzyme-blocking therapy led to the encapsulation of the tumors, stopping them from spreading further.

In 1980, a group of scientists from the University of Tokyo led by Dr. Suma published the following:

The treatment was successful in a patient with advanced, inoperable ovarian cancer. The disease had already caused secondary tumors and fluid accumulation in the stomach. Even in this advanced stage the cancer was brought to a standstill with the help of enzyme block therapy. The researchers had observed the development of the disease for several years and closed the case as follows: "Three years after the start of the treatment the patient had no more complaints."

By far the most common form of cancer in women is breast cancer, followed by uterine and ovarian cancers. The physiology of the breast tissue and its hormonal restructuring during the monthly cycle makes it particularly prone to cancerous transformations. If there is some kind of disturbance in the regulatory mechanisms, the tissue slips toward steady restructuring, which eventually can lead to uncontrolled growth of tissue and the formation of tumors.

Considering the fact that in Europe alone hundreds of thousands of women die of this form of cancer every year, the question poses itself: Why does it take so long before safe and potentially successful forms of therapy, such as enzyme-blocking therapy, are generally applied? The answer is simple: Cancer and chemotherapeutic drugs are the second-most lucrative market for the pharmaceutical industry after the heart disease market. The global market for chemotherapeutics alone makes a profit of over a hundred billion dollars a year. This is why the pharmaceutical industry has no interest in the development of therapies that could put an end to cancer.

Even in the few cases when the blocking of collagen-digesting enzymes was studied, only synthetic derivatives of lysine were used. The reason is also economical: contrary to the natural lysine, its chemically modified forms could be patented and therefore be profitable for the pharmaceutical business. A wider use of even these patented substances could also mean the end of cancer.

For years the first successful reports on this new therapy have been ignored by the pharmaceutical industry. It was only in 1992, with the publication of my scientific research, that the meaning of this medical breakthrough and the therapeutic use of lysine in all fields of medicine became known.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment